Voloridge Investment Management
BOLD

Voloridge Investment Management’s Audentes Therapeutics, Inc BOLD Stock Holding History

Voloridge Investment Management’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-37,355
Closed -$2.23M – 1556
2019
Q4 		$2.23M Buy
37,355
+27,683
+286% +$1.04M 0.04% 468
2019
Q3 		$272K Sell
9,672
-16,568
-63% -$565K ﹤0.01% 949
2019
Q2 		$993K Buy
+26,240
New +$1.01M 0.03% 458

Voloridge Investment Management's BOLD Position: Q1 2020 in Review

Voloridge Investment Management sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 37,355 shares — an estimated $2.23M sold.

Voloridge Investment Management first reported a position in BOLD in Q2 2019 and held it in 3 quarters. The position peaked at $2.23M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

  • Voloridge Investment Management reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
  • Voloridge Investment Management sold 37,355 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $2.23M.
  • Voloridge Investment Management first reported a position in Audentes Therapeutics, Inc in Q2 2019 and held it in 3 quarters.
  • Voloridge Investment Management's Audentes Therapeutics, Inc position peaked at $2.23M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Voloridge Investment Management's 13F filing for Q1 2020, filed 15 May 2020.